NASDAQ: HKPDCellyan Biotechnology Co Revenue
Cellyan Biotechnology Co revenue was $13.43M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was N/A, down N/A from last quarter. For the last reported fiscal year 2026 ending Mar 31, 2026, HKPD annual revenue was $13.4M, with -33.9% growth year-over-year.
HKPD past revenue growth
How has HKPD's revenue growth performed historically?
Company
-33.87%
Industry
37.5%
Market
34.6%
HKPD's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HKPD's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HKPD revenue history
Current Revenue
$13.4M
Current Earnings
-$1.1M
Current Profit Margin
-8.5%
Be the first to know when HKPD announces revenue.
HKPD Revenue History By Year
| HKPD Yearly Revenue | HKPD Revenue | HKPD Change | HKPD Revenue Growth |
|---|---|---|---|
| 2026-03-31 | $13.43M | -$6.88M | -33.87% |
| 2025-03-31 | $20.31M | $3.63M | +21.72% |
| 2024-03-31 | $16.69M | $4.13M | +32.91% |
| 2023-03-31 | $12.56M | N/A | N/A |
Cellyan Biotechnology Co Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.